Public annual accounts

ALGEMENE BOUWONDERNEMING NELISSEN STEFAN financials

A multi-period view of the public annual-account figures reported for ALGEMENE BOUWONDERNEMING NELISSEN STEFAN, with comparable measures and links to available source documents.

Company overview
Registry number

0837153946

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jun 30, 2025

Financial evidence

2025 versus 2024

Operating line
€32,997

-37.4%

EBITDA
€31,613

-37.4%

Total assets
€211,125

+14.9%

Equity
€122,182

+4.5%

EBITDA margin +95.8% · Equity ratio +57.9%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202530 Jun 2025€32,997€31,613€211,125€122,182-
202430 Jun 2024€52,702€50,515€183,745€116,882-
Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report